Oct 25, 07
|
| NEW STORY |
| 06:00 ET |
ZymoGenetics to Host Conference Call and Webcast on October 31, 2007 to Discuss Third Quarter Results
|
|
Oct 23, 07
|
| 13:30 ET |
ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
|
|
Oct 04, 07
|
| 06:00 ET |
ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
|
|
Sep 06, 07
|
| 06:00 ET |
ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
|
|
Aug 22, 07
|
| 16:05 ET |
ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
|
|
Aug 01, 07
|
| 06:00 ET |
ZymoGenetics Reports Second Quarter 2007 Financial Results
|
|
Jul 25, 07
|
| 06:00 ET |
ZymoGenetics to Host Conference Call and Webcast on August 1, 2007 to Discuss Q2 2007 Financial Results
|
|
Jul 02, 07
|
| 06:00 ET |
ZymoGenetics Announces Senior Management Promotions
|
|
Jun 19, 07
|
| 07:30 ET |
ZymoGenetics Will Hold Conference Call on June 19 at 8:30 a.m. Eastern Time to Discuss rThrombin Collaboration with Bayer HealthCare
|
|
| 02:01 ET |
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
|
|
Jun 04, 07
|
| 06:00 ET |
ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
|
|
May 29, 07
|
| 06:00 ET |
ZymoGenetics Announces Upcoming Presentations at ASCO
|
|
May 17, 07
|
| 06:00 ET |
ZymoGenetics to Webcast Presentations at Two Upcoming Investor Conferences
|
|
May 02, 07
|
| 16:05 ET |
ZymoGenetics Reports First Quarter 2007 Financial Results
|
|
Apr 26, 07
|
| 06:00 ET |
ZymoGenetics to Host Conference Call and Webcast on May 2, 2007 to Discuss Q1 2007 Financial Results
|
|
Apr 25, 07
|
| 06:00 ET |
ZymoGenetics to Webcast Presentation at Morgan Stanley Healthcare Conference
|
|
Mar 12, 07
|
| 06:00 ET |
ZymoGenetics to Webcast Presentations at Two Upcoming Investor Conferences
|
|
Mar 07, 07
|
| 06:00 ET |
ZymoGenetics Provides Update on rhThrombin Development Plans
|
|
Feb 26, 07
|
| 12:16 ET |
ZymoGenetics to Webcast Presentation at RBC Dain Rauscher Northwest Investor Conference
|
|
Feb 15, 07
|
| 16:05 ET |
FDA Accepts ZymoGenetics' Recombinant Human Thrombin Application for Review
|
|
| 16:01 ET |
ZymoGenetics Reports Fourth Quarter and Year End 2006 Financial Results
|
|
Feb 07, 07
|
| 06:00 ET |
ZymoGenetics to Host Conference Call and Webcast on February 15, 2007 to Discuss 2006 Year-end Financial Results
|
|
Feb 01, 07
|
| 06:00 ET |
ZymoGenetics to Webcast Presentations at Two Upcoming Investor Conferences
|
|
Jan 30, 07
|
| 06:00 ET |
ZymoGenetics Begins Clinical Trial for PEG-Interferon lambda as Potential Treatment for Viral Infection
|
|
Jan 04, 07
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at JP Morgan Healthcare Conference
|
|
Dec 20, 06
|
| 01:00 ET |
ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis
|
|
Dec 18, 06
|
| 06:00 ET |
ZymoGenetics Submits Biologics License Application to the FDA for rhThrombin as an Aid to Controlling Bleeding During Surgery
|
|
Dec 14, 06
|
| 16:10 ET |
ZymoGenetics Highlights Development Programs at Annual Analyst & Investor Briefing
|
|
Dec 12, 06
|
| 08:30 ET |
ZymoGenetics Presents Results From Two Atacicept Phase 1b Clinical Trials in B-Cell Cancer
|
|
Nov 21, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Piper Jaffray Conference
|
|
Nov 13, 06
|
| 01:00 ET |
ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus
|
|
Nov 10, 06
|
| 06:00 ET |
ZymoGenetics to Review Development Programs at Credit Suisse Conference
|
|
Nov 01, 06
|
| 16:05 ET |
ZymoGenetics Reports Third Quarter 2006 Financial Results
|
|
Oct 25, 06
|
| 06:00 ET |
ZymoGenetics to Host Conference Call and Webcast on November 1, 2006 to Discuss Third Quarter Results
|
|
Oct 17, 06
|
| 06:00 ET |
ZymoGenetics Begins Phase 1/2 Clinical Trial With IL-21 and Nexavar in Patients With Renal Cell Cancer
|
|
Sep 20, 06
|
| 17:00 ET |
ZymoGenetics to Highlight Development Programs at UBS Global Life Sciences Conference
|
|
Sep 18, 06
|
| 06:00 ET |
ZymoGenetics Discusses Detailed Results From Successful Phase 3 Trial Evaluating rhThrombin as a Potential Treatment for Surgical Bleeding
|
|
Sep 05, 06
|
| 16:10 ET |
ZymoGenetics Reports Positive Results From Pivotal Phase 3 Clinical Trial of rhThrombin
|
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Upcoming Bear Stearns Healthcare Conference
|
|
Aug 14, 06
|
| 16:05 ET |
ZymoGenetics Files Lawsuit Against Bristol-Myers Squibb for Infringement of Fusion Protein Patents
|
|
Aug 03, 06
|
| 06:00 ET |
ZymoGenetics Reports Second Quarter 2006 Financial Results
|
|
Jul 25, 06
|
| 06:00 ET |
ZymoGenetics Releases Preliminary Findings From Atacicept (TACI-Ig) Phase 1b Studies in Patients With Lupus
|
|
Jul 12, 06
|
| 06:00 ET |
ZymoGenetics Begins Phase 1 Trial With IL-21 and Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
|
|
Jun 26, 06
|
| 01:00 ET |
ZymoGenetics and Serono Present Positive Results of TACI-Ig Phase 1b Trial in Rheumatoid Arthritis at EULAR Meeting
|
|
Jun 20, 06
|
| 06:00 ET |
ZymoGenetics Completes Enrollment for rhThrombin Phase 3 Trial
|
|
Jun 07, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Pacific Growth Equities Investor Conference
|
|
Jun 05, 06
|
| 06:00 ET |
ZymoGenetics Reports Encouraging IL-21 Phase 1b Results in Metastatic Melanoma and Renal Cell Cancer Presented at ASCO Meeting
|
|
May 11, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Two Upcoming Investor Conferences
|
|
May 04, 06
|
| 06:00 ET |
ZymoGenetics Reports First Quarter 2006 Financial Results
|
|
May 03, 06
|
| 06:00 ET |
ZymoGenetics Names Vaughn Himes Senior Vice President of Technical Operations
|
|
May 01, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Morgan Stanley Global Healthcare Unplugged Conference
|
|
Apr 25, 06
|
| 06:00 ET |
ZymoGenetics Names Michael Dwyer Senior Vice President of Marketing and Sales
|
|
Mar 15, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Invest Northwest Conference
|
|
Mar 13, 06
|
| 06:00 ET |
Dr. Judith Hemberger Joins ZymoGenetics Board of Directors
|
|
Mar 02, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Lehman Brothers Investor Conference
|
|
Feb 15, 06
|
| 06:00 ET |
George B. Rathmann, Ph.D. to Retire from ZymoGenetics Board of Directors
|
|
Feb 10, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at Upcoming BIO CEO & Investor Conference
|
|
Feb 09, 06
|
| 06:00 ET |
ZymoGenetics Reports Fourth Quarter and Year End 2005 Financial Results
|
|
Feb 02, 06
|
| 06:03 ET |
ZymoGenetics to Highlight Development Programs at Upcoming Merrill Lynch Investor Conference
|
|
Jan 10, 06
|
| 06:00 ET |
ZymoGenetics Reports Preliminary Positive Results From TACI-Ig Phase 1b Study in Patients With Rheumatoid Arthritis
|
|
Jan 05, 06
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs and Discuss Preliminary Findings from TACI-Ig Phase 1b Clinical Trial in RA at Upcoming Investor Conference
|
|
Dec 12, 05
|
| 13:00 ET |
ZymoGenetics Announces Presentation of TACI-Ig Phase 1 Preliminary Findings in Multiple Myeloma at American Society of Hematology Meeting
|
|
Dec 08, 05
|
| 13:00 ET |
ZymoGenetics Highlights Development Programs at Analyst & Investor Briefing
|
|
Nov 14, 05
|
| 06:01 ET |
ZymoGenetics Presents IL-21 Clinical Study Results at International Society for Biological Therapy of Cancer Conference
|
|
Nov 03, 05
|
| 06:00 ET |
ZymoGenetics Reports Third Quarter 2005 Financial Results
|
|
Nov 02, 05
|
| 06:00 ET |
ZymoGenetics to Highlight Development Programs at the Rodman & Renshaw TechVest 7th Annual Healthcare Conference
|
|